A price-hiking drug company has been hit by the UK watchdog’s biggest ever fine

The Competition and Markets Authority (CMA) has fined drug company Pfizer a record £84.2m for its role in ramping up the cost of an epilepsy drug by 2,600%.

The medication in question is phenytoin. This drug is widely used for a range of epileptic seizures. Pfizer used to market the drug under the name Epanutin, but then sold the rights to British company Flynn Pharma. It was then debranded, which meant it was no longer subject to price regulation. 100mg packs of the capsules soared from £2.83 to £67.50 in 2012, reducing to £54 in May 2014. As a result, NHS spending on the drug rose from £2m to £50m in a year. The company was able to do this because there was little competition.

Cruel profit-making

This record fine brings into focus how unethical these drug price hikes are. Philip Marsden, chairman of the CMA’s case decision group, said:

The companies deliberately exploited the opportunity offered by debranding to hike up the price for a drug which is relied upon by many thousands of patients.

He added:

This is the highest fine the CMA has imposed and it sends out a clear message to the sector that we are determined to crack down on such behaviour.

Both Pfizer and Flynn plan to appeal the CMA’s verdict. Flynn chief executive David Fakes argues it is unfair for them to be punished because they were still selling the phenytoin in capsule form for 25-40% less than phenytoin tablets produced by another supplier.

Read on...

But the CMA might not buy into this line of argument. Just because other suppliers are charging even more for this drug, it does not justify Flynn’s massive rise in pricing. Pointing to greater wrongdoing doesn’t lessen the blame. Flakes is right in one respect, though. Sky-high drug prices are a huge problem in Big Pharma. And that’s the case whether it’s the NHS picking up the bill, or individuals.

Business as usual

A US study published back in August concluded that:

High drug prices are the result of the approach the United States has taken to granting government-protected monopolies to drug manufacturers…

There are many disturbing facts about the high price of prescription drugs:

  • Prices increased at eight times the rate of inflation [paywall] for 30 prescription drugs.
  • The average annual retail price of drugs was over $11,000 in 2013 for a patient with a chronic illness.
  • Denmark spends only 35 cents per capita on prescription drugs for every $1 spent by the US.
  • 20% of Americans who take prescription drugs say they or a family member have not taken the prescribed dose because the drugs are so expensive.
  • 55% of adults aged 50 and over did not refill a prescription because of the cost involved.

As previously reported at The Canary, pharma CEO Martin Shkreli caused outrage when he jacked up the price of life-saving HIV drug Daraprim from $13 to $750 per pill. That’s a rise of over 5,000%. And it put this essential medicine out of reach for pretty much everyone who needs it.

Not all hope is lost…

Some students in Australia recently made Daraprim in their high school lab for about $2 a dose. This endeavour, along with the CMA’s decision, shows that there is clearly a lot of pushback against Big Pharma’s most unethical practices. No patient should be forced to deny themselves the medicine that they need.

Get Involved!

– Check out more articles from The Canary on Health.

– Support Epilepsy Action, Epilepsy Research, and the Epilepsy Society.

Featured image via TBIT/Pixabay

We need your help to keep speaking the truth

Every story that you have come to us with; each injustice you have asked us to investigate; every campaign we have fought; each of your unheard voices we amplified; we do this for you. We are making a difference on your behalf.

Our fight is your fight. You’ve supported our collective struggle every time you gave us a like; and every time you shared our work across social media. Now we need you to support us with a monthly donation.

We have published nearly 2,000 articles and over 50 films in 2021. And we want to do this and more in 2022 but we don’t have enough money to go on at this pace. So, if you value our work and want us to continue then please join us and be part of The Canary family.

In return, you get:

* Advert free reading experience
* Quarterly group video call with the Editor-in-Chief
* Behind the scenes monthly e-newsletter
* 20% discount in our shop

Almost all of our spending goes to the people who make The Canary’s content. So your contribution directly supports our writers and enables us to continue to do what we do: speaking truth, powered by you. We have weathered many attempts to shut us down and silence our vital opposition to an increasingly fascist government and right-wing mainstream media.

With your help we can continue:

* Holding political and state power to account
* Advocating for the people the system marginalises
* Being a media outlet that upholds the highest standards
* Campaigning on the issues others won’t
* Putting your lives central to everything we do

We are a drop of truth in an ocean of deceit. But we can’t do this without your support. So please, can you help us continue the fight?

The Canary Support us

Comments are closed